Pinealon 10mg

Pinealon 10mg — Tripeptide Bioregulator for Neuroprotection and Aging Research

Pinealon is a synthetic tripeptide with sequence Glu-Asp-Arg, developed as part of the Russian peptide bioregulator research program led by Vladimir Khavinson. Despite its minimal three-amino-acid structure, Pinealon has been characterized in published research for effects on neurological function, oxidative stress, and aging biomarkers. The peptide represents an interesting class of minimal-size bioregulators within the nootropic peptides research category.

Bioregulator Hypothesis

Pinealon belongs to a class of compounds described by Russian researchers as peptide bioregulators, hypothesized to act through epigenetic modulation of gene expression rather than classical receptor-mediated signaling. Research has documented effects on gene expression patterns affecting multiple biological pathways, supporting the hypothesis that short peptides can produce broad biological effects through transcriptional regulation in living tissue.

Neuroprotective Research

Pinealon’s most studied effects involve neuroprotection. Research has documented protective effects against various neurotoxic challenges in cellular and animal models, including protection against oxidative stress, glutamate excitotoxicity, and other forms of neuronal injury. These neuroprotective effects have positioned Pinealon as a research tool for investigating mechanisms of neuronal protection in models of degeneration.

Oxidative Stress and Antioxidant Research

Research has characterized Pinealon’s effects on oxidative stress markers and antioxidant defense systems. Studies have documented modulation of antioxidant enzyme expression, reduction of oxidative damage markers, and effects on free radical generation in various cellular and animal model systems. These antioxidant effects contribute to the peptide’s broader neuroprotective profile.

Cognitive and Aging Research

Pinealon has been studied for effects on cognitive function in aging models, where oxidative stress contributes to age-related cognitive decline. Research has documented effects on cognitive performance, neurochemistry, and aging biomarkers in animal models. These effects align with the broader peptide bioregulator framework, which has examined effects on aging across multiple Russian research programs.

Mechanistic Research

Mechanistic studies have begun characterizing how a minimal tripeptide like Pinealon produces such diverse biological effects. Research has documented effects on gene expression patterns, DNA-peptide interactions, and epigenetic mechanisms that may underlie the broad biological footprint of these short peptides. This research is contributing to understanding of how minimal peptide sequences can modulate complex biological systems.

Comparison With Related Nootropic and Aging Peptides

Pinealon is frequently studied alongside other nootropic peptides such as Selank, Semax, and DSIP, as well as related bioregulator peptides like Epithalon. Parallel investigations help characterize how minimal-sequence bioregulators compare against longer signalling peptides in matched experimental designs.

Quality, Storage, and Compliance

Each vial of Pinealon 10mg is manufactured to 99%+ HPLC-verified purity and supplied as a sterile lyophilized powder. Store unreconstituted vials at -20°C; reconstituted material should be refrigerated at 2–8°C. This Pinealon product is sold strictly for in-vitro laboratory research only — not for human consumption, diagnostic use, or any clinical application. Buyers must comply with all applicable provincial and federal regulations.